Brooks Laboratories Limited (BROOKS.BO)

INR 162.3

(1.98%)

Total Liabilities Summary of Brooks Laboratories Limited

  • Brooks Laboratories Limited's latest annual total liabilities in 2023 was 248.6 Million INR , down -30.25% from previous year.
  • Brooks Laboratories Limited's latest quarterly total liabilities in 2024 Q1 was -655.85 Million INR , down -363.82% from previous quarter.
  • Brooks Laboratories Limited reported annual total liabilities of 356.44 Million INR in 2022, down -42.13% from previous year.
  • Brooks Laboratories Limited reported annual total liabilities of 615.91 Million INR in 2021, down -25.73% from previous year.
  • Brooks Laboratories Limited reported quarterly total liabilities of 248.6 Million INR for 2023 FY, down -30.25% from previous quarter.
  • Brooks Laboratories Limited reported quarterly total liabilities of 268.74 Million INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Brooks Laboratories Limited (2023 - 2007)

Historical Annual Total Liabilities of Brooks Laboratories Limited (2023 - 2007)

Year Total Liabilities Total Liabilities Growth
2023 248.6 Million INR -30.25%
2022 356.44 Million INR -42.13%
2021 615.91 Million INR -25.73%
2020 829.28 Million INR 39.5%
2019 594.48 Million INR -5.24%
2018 627.32 Million INR 7.8%
2017 581.95 Million INR 62.32%
2016 358.53 Million INR 28.84%
2015 278.28 Million INR 15.33%
2014 241.3 Million INR 19.6%
2013 201.75 Million INR -23.15%
2012 262.52 Million INR 69.39%
2011 154.98 Million INR -27.7%
2010 214.36 Million INR -9.22%
2009 236.14 Million INR 0.14%
2008 235.82 Million INR 15.2%
2007 204.7 Million INR 0.0%

Peer Total Liabilities Comparison of Brooks Laboratories Limited

Name Total Liabilities Total Liabilities Difference
Ajanta Pharma Limited 10.71 Billion INR 97.679%
Amrutanjan Health Care Limited 783.82 Million INR 68.284%
Sigachi Industries Limited 2.53 Billion INR 90.179%
Bal Pharma Limited 2.51 Billion INR 90.101%
Ind-Swift Laboratories Limited 2.28 Billion INR 89.142%
Medico Remedies Limited 438.24 Million INR 43.273%
Lasa Supergenerics Limited 541.92 Million INR 54.126%
Venus Remedies Limited 1.39 Billion INR 82.151%
Sun Pharma Advanced Research Company Limited 3.89 Billion INR 93.614%
Alpa Laboratories Limited 307.12 Million INR 19.055%
Nectar Lifesciences Limited 11.21 Billion INR 97.784%
Shilpa Medicare Limited 12.93 Billion INR 98.078%
Aarti Drugs Limited 11.5 Billion INR 97.839%
Lupin Limited 96.23 Billion INR 99.742%
Aurobindo Pharma Limited 152.2 Billion INR 99.837%
Zydus Lifesciences Limited 71.79 Billion INR 99.654%
Windlas Biotech Limited 1.76 Billion INR 85.897%
Suven Life Sciences Limited 148.62 Million INR -67.272%
Eris Lifesciences Limited 38.26 Billion INR 99.35%
Valiant Laboratories Limited 1.05 Billion INR 76.508%
J. B. Chemicals & Pharmaceuticals Limited 10.7 Billion INR 97.678%
Solara Active Pharma Sciences Limited 14.14 Billion INR 98.242%
Ipca Laboratories Limited 33.74 Billion INR 99.263%
Bliss GVS Pharma Limited 2.1 Billion INR 88.212%
Achyut Healthcare Limited 2.01 Million INR -12249.776%
Sun Pharmaceutical Industries Limited 183.56 Billion INR 99.865%
Bajaj HealthCare Limited 4.86 Billion INR 94.893%
RPG Life Sciences Limited 1.38 Billion INR 81.988%
Mankind Pharma Limited 23.87 Billion INR 98.959%
Laurus Labs Limited 42.71 Billion INR 99.418%
Piramal Pharma Limited 74 Billion INR 99.664%
Syncom Formulations (India) Limited 1.16 Billion INR 78.665%
Torrent Pharmaceuticals Limited 82.05 Billion INR 99.697%
Alembic Pharmaceuticals Limited 16.27 Billion INR 98.472%
Glenmark Pharmaceuticals Limited 65.11 Billion INR 99.618%
Unichem Laboratories Limited 8.06 Billion INR 96.919%
Sequent Scientific Limited 8.27 Billion INR 96.995%
Novartis India Limited 1.8 Billion INR 86.197%
Wanbury Limited 3.15 Billion INR 92.122%
Suven Pharmaceuticals Limited 2.03 Billion INR 87.779%
Wockhardt Limited 39.87 Billion INR 99.376%
Themis Medicare Limited 1.88 Billion INR 86.829%
Jagsonpal Pharmaceuticals Limited 296.76 Million INR 16.228%
Jubilant Pharmova Limited 61.27 Billion INR 99.594%
Glenmark Life Sciences Limited 5.18 Billion INR 95.202%
Dr. Reddy's Laboratories Limited 106.96 Billion INR 99.768%
Divi's Laboratories Limited 18.99 Billion INR 98.691%
NATCO Pharma Limited 10.53 Billion INR 97.64%
Gufic Biosciences Limited 5.59 Billion INR 95.561%
IOL Chemicals and Pharmaceuticals Limited 6.32 Billion INR 96.072%
Ind-Swift Limited 13.45 Billion INR 98.152%
Procter & Gamble Health Limited 2.56 Billion INR 90.294%
FDC Limited 3.7 Billion INR 93.298%
Krebs Biochemicals & Industries Limited 2.97 Billion INR 91.641%
Granules India Limited 22.95 Billion INR 98.917%
Medicamen Biotech Limited 940.36 Million INR 73.563%
Alkem Laboratories Limited 48.6 Billion INR 99.489%
AstraZeneca Pharma India Limited 3.66 Billion INR 93.21%
Biofil Chemicals and Pharmaceuticals Limited 288.79 Million INR 13.919%
Megasoft Limited 1.85 Billion INR 86.585%
ZIM Laboratories Limited 2.08 Billion INR 88.052%
Strides Pharma Science Limited 37.68 Billion INR 99.34%
Neuland Laboratories Limited 5.49 Billion INR 95.479%
Morepen Laboratories Limited 4.45 Billion INR 94.426%
Hikal Limited 12.99 Billion INR 98.087%
Indoco Remedies Limited 10.34 Billion INR 97.596%
Aarti Pharmalabs Limited 8.25 Billion INR 96.987%
Kilitch Drugs (India) Limited 643.88 Million INR 61.39%
Mangalam Drugs & Organics Limited 1.97 Billion INR 87.421%
Hester Biosciences Limited 3.59 Billion INR 93.084%